Suppression of T cell signaling by polyunsaturated fatty acids: selectivity in inhibition of mitogen-activated protein kinase and nuclear factor activation

J Immunol. 2003 Jun 15;170(12):6033-9. doi: 10.4049/jimmunol.170.12.6033.

Abstract

Polyunsaturated fatty acids (PUFAs) are known to suppress inflammatory and autoimmune responses and, therefore, clinical applications of PUFAs as immunomodulatory substances are extensively studied. PUFAs are known to inhibit T cell responses, but with respect to TCR/CD3-mediated signal transduction only a block in CD3-induced phospholipase Cgamma1/calcium signaling has been shown so far. In this study, we investigated PUFA-mediated changes in downstream T cell signal transduction. We show that among the mitogen-activated protein kinase families activation of c-Jun NH(2)-terminal kinase, but not phosphorylation of extracellular signal-regulated kinase-1/-2 or p38 is inhibited. CD3/CD28-induced activity of NF-AT was markedly reduced by PUFA treatment, while activation of other nuclear receptors (AP-1 and NF-kappaB) remained unaltered. Furthermore, IL-2 promoter activity, IL-2 and IL-13 mRNA levels, IL-2 secretion, and IL-2R alpha-chain expression were significantly diminished by PUFA treatment, whereas the expression of IFN-gamma, IL-4, IL-10, and CD69 remained essentially unaffected by PUFAs. In conclusion, PUFA treatment of T cells inhibits selectively c-Jun NH(2)-terminal kinase and NF-AT activation, resulting in diminished production of IL-2 and IL-13.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Down-Regulation / drug effects
  • Down-Regulation / immunology
  • Enzyme Activation / drug effects
  • Enzyme Activation / immunology
  • Fatty Acids, Unsaturated / pharmacology*
  • Humans
  • Immunosuppressive Agents / pharmacology*
  • Interleukin-13 / antagonists & inhibitors
  • Interleukin-13 / biosynthesis
  • Interleukin-2 / antagonists & inhibitors
  • Interleukin-2 / biosynthesis
  • JNK Mitogen-Activated Protein Kinases
  • Jurkat Cells
  • Lymphocyte Activation / drug effects
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Protein Subunits / antagonists & inhibitors
  • Protein Subunits / biosynthesis
  • Receptors, Interleukin-2 / antagonists & inhibitors
  • Receptors, Interleukin-2 / biosynthesis
  • Signal Transduction / drug effects*
  • Signal Transduction / immunology*
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / enzymology*
  • T-Lymphocytes / metabolism

Substances

  • Adjuvants, Immunologic
  • Fatty Acids, Unsaturated
  • Immunosuppressive Agents
  • Interleukin-13
  • Interleukin-2
  • NF-kappa B
  • Protein Subunits
  • Receptors, Interleukin-2
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases